These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 10442753)

  • 1. Botox for hyperadduction of the false vocal folds: a case report.
    Rosen CA; Murry T
    J Voice; 1999 Jun; 13(2):234-9. PubMed ID: 10442753
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of ventricular dysphonia with botulinum toxin.
    Kendall KA; Leonard RJ
    Laryngoscope; 1997 Jul; 107(7):948-53. PubMed ID: 9217137
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spasmodic dysphonia combined with insufficient glottic closure by phonation.
    Kaszás Z; Lichtenberger G; Mészáros K; Falvai J
    Eur Arch Otorhinolaryngol; 2003 Sep; 260(8):418-20. PubMed ID: 12709812
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Botulinum toxin treatment of false vocal folds in adductor spasmodic dysphonia: Functional outcomes.
    Simpson CB; Lee CT; Hatcher JL; Michalek J
    Laryngoscope; 2016 Jan; 126(1):118-21. PubMed ID: 26467807
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A prospective crossover trial of botulinum toxin chemodenervation versus injection augmentation for essential voice tremor.
    Estes C; Sadoughi B; Coleman R; Sarva H; Mauer E; Sulica L
    Laryngoscope; 2018 Feb; 128(2):437-446. PubMed ID: 28988441
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Botulinum toxin efficacy in the treatment of patients with spasmodic dysphonia].
    Svetel M; Vasić M; Tomić G; Stanković P; Stojanović M; Dragasević N; Dergenc R; Vukasinović M; Pekmezović T; Petrović I; Kostić V
    Vojnosanit Pregl; 2007 Oct; 64(10):671-5. PubMed ID: 18041568
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnosis and management of ventricular dysphonia.
    Von Hake CP; Ganzman IP; Mauer TP
    J Am Osteopath Assoc; 1989 Feb; 89(2):181-3. PubMed ID: 2925458
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of supraglottic squeeze in adductor spasmodic dysphonia: a new technique.
    Young N; Blitzer A
    Laryngoscope; 2007 Nov; 117(11):2082-4. PubMed ID: 17828055
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Paradoxical vocal fold movement: a case report.
    Pinho SM; Tsuji DH; Sennes L; Menezes M
    J Voice; 1997 Sep; 11(3):368-72. PubMed ID: 9297683
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Office-based laryngeal injection of botulinum toxin for paradoxical vocal fold motion in a child.
    Montojo J; González R; Hernández E; Zafra M; Plaza G
    Int J Pediatr Otorhinolaryngol; 2015 Jul; 79(7):1161-3. PubMed ID: 26032616
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An in vivo canine model for testing treatment effects in laryngeal hyperadduction disorders.
    Green DC; Berke GS
    Laryngoscope; 1990 Nov; 100(11):1229-35. PubMed ID: 2233089
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Paradoxical vocal cord motion--a case report.
    Lo HI; Ho HC; Hwang JH
    Auris Nasus Larynx; 2005 Dec; 32(4):427-30. PubMed ID: 16039815
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Singer's dystonia: first report of a variant of spasmodic dysphonia.
    Chitkara A; Meyer T; Keidar A; Blitzer A
    Ann Otol Rhinol Laryngol; 2006 Feb; 115(2):89-92. PubMed ID: 16514788
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of botulinum toxin therapy in patients with adductor spasmodic dysphonia: acoustic, aerodynamic, and videoendoscopic findings.
    Zwirner P; Murry T; Swenson M; Woodson GE
    Laryngoscope; 1992 Apr; 102(4):400-6. PubMed ID: 1556889
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Botox treatment in adductor spasmodic dysphonia: a meta-analysis.
    Boutsen F; Cannito MP; Taylor M; Bender B
    J Speech Lang Hear Res; 2002 Jun; 45(3):469-81. PubMed ID: 12069000
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of patient factors on response outcomes to Botox treatment of spasmodic dysphonia.
    Lundy DS; Lu FL; Casiano RR; Xue JW
    J Voice; 1998 Dec; 12(4):460-6. PubMed ID: 9988033
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Botulinum toxin management of adductor spasmodic dysphonia after failed recurrent laryngeal nerve section.
    Sulica L; Blitzer A; Brin MF; Stewart CF
    Ann Otol Rhinol Laryngol; 2003 Jun; 112(6):499-505. PubMed ID: 12834116
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Diagnostic and therapeutic difficulties in laryngeal dystonia].
    Niebudek-Bogusz E; Modzelewska-Radwan B; Pietruszewska W; Zielińska M; Gryczyński M
    Otolaryngol Pol; 2003; 57(5):739-45. PubMed ID: 14994622
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of repeated botulinum toxin injections as a function of timing.
    Inagi K; Ford CN; Rodriquez AA; Schultz E; Bless DM; Heisey DM
    Ann Otol Rhinol Laryngol; 1997 Dec; 106(12):1012-9. PubMed ID: 9415596
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acoustic variations in reading produced by speakers with spasmodic dysphonia pre-botox injection and within early stages of post-botox injection.
    Sapienza CM; Cannito MP; Murry T; Branski R; Woodson G
    J Speech Lang Hear Res; 2002 Oct; 45(5):830-43. PubMed ID: 12381042
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.